Pivotal bioVenture Partners Investment Advisor LLC
CIK: 0001844645SEC EDGAR →
Portfolio Value
$258.7B
Holdings
12
As of
Q4 2025
New Positions
10
Closed Positions
0
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | VAXCYTE INC | 1,372,425 | $63.3B | 24.48% |
| 2 | OCULIS HOLDING AG | 2,288,658 | $45.7B | 17.67% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | 1,366,624 | $39.7B | 15.34% |
| 4 | EVOMMUNE INC | 1,926,943 | $33.0B | 12.75% |
| 5 | ZENAS BIOPHARMA INC | 591,991 | $21.5B | 8.31% |
| 6 | TREVI THERAPEUTICS INC | 1,256,782 | $15.7B | 6.08% |
| 7 | IMMUNOME INC | 732,512 | $15.7B | 6.08% |
| 8 | MAPLIGHT THERAPEUTICS INC | 611,447 | $10.7B | 4.15% |
| 9 | BIOAGE LABS INC | 653,374 | $8.6B | 3.34% |
| 10 | RECURSION PHARMACEUTICALS IN | 595,518 | $2.4B | 0.94% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 12 | $258.7B | 100.0% |